ERS Genomics
ERS Genomics and IRBM sign license agreement for CRISPR/Cas9
May 20, 2024Research and Development CRISPR/Cas9, ERS Genomics, IRBM, License Agreement, Pharmacy
ERS Genomics and IRBM have announced that they have entered into a non-exclusive CRISPR/Cas9 license agreement, granting IRBM access to …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
